What ADME tests should be conducted for preclinical studies?
The pharmaceutical industry has been evolving in recent years, which made numerous CROs and biotech companies conducting drug discovery and development programs and services in China. As a very comprehensive and important technology platform bridging efficacy and safety, the DMPK has become a mature...
Saved in:
Main Author: | Hong Wan (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overall Comparison of Small Molecules and Large Biologics in ADME Testing
by: Hong Wan
Published: (2016) -
An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data
by: Alexander D. James, et al.
Published: (2020) -
CMC development of [14C]-labeled sotorasib for the conduct of microtracer human ADME study
by: Sonika Sharma, et al.
Published: (2023) -
Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies
by: Jiawang Liu, et al.
Published: (2021) -
Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissues
by: Kip P. Conner, et al.
Published: (2020)